Phase-I trial of combination chemotherapy and donor lymphocyte infusion for relapsed aggressive hematologic malignancies following allogeneic bone marrow transplantation.

被引:0
|
作者
Mookerjee, B
Couzi, R
Seber, A
Miller, C
Noga, S
Douglas, T
Altomonte, V
Gore, S
Jones, R
Vogelsang, G
Fuchs, E
机构
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
708
引用
收藏
页码:162A / 162A
页数:1
相关论文
共 50 条
  • [1] Combination chemotherapy and donor lymphocyte infusion for treatment of aggressive hematologic malignancies in relapse after allogeneic bone marrow transplantation.
    Mookerjee, B
    Couzi, R
    Seber, A
    Miller, C
    Noga, S
    Douglas, T
    Altomonte, V
    Gore, S
    Jones, R
    Vogelsang, G
    Fuchs, E
    CLINICAL CANCER RESEARCH, 1999, 5 : 3734S - 3734S
  • [2] Donor lymphocyte infusion(DLI) in relapsed, hematologic malignancies after allogeneic stem cell transplantation.
    Lee, KE
    Jung, CW
    Kim, M
    Lee, MH
    Park, K
    Kim, DY
    Yoon, SS
    Park, SA
    Kim, BK
    BLOOD, 2002, 100 (11) : 453B - 453B
  • [3] Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program
    Miyamoto, Toshihiro
    Fukuda, Takahiro
    Nakashima, Marie
    Henzan, Tomoko
    Kusakabe, Shinsuke
    Kobayashi, Naoki
    Sugita, Junichi
    Mori, Takeshi
    Kurokawa, Mineo
    Mori, Shin-ichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (06) : 938 - 944
  • [4] Expansion of pre-existing clonal populations following donor lymphocyte infusion for relapsed multiple myeloma after allogeneic bone marrow transplantation.
    Orsini, E
    Alyea, EP
    Schlossman, R
    Soiffer, RJ
    Anderson, KC
    Ritz, J
    BLOOD, 1997, 90 (10) : 2446 - 2446
  • [5] Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies
    Luo, Yun
    Zeng, Han-Qing
    Shen, Yan
    Zhang, Ping
    Lou, Shi-Feng
    Chen, Lin
    Deng, Jian-Chuan
    LEUKEMIA RESEARCH, 2016, 48 : 6 - 10
  • [6] Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation
    Zeder, K
    Waller, EK
    Redei, I
    Connaghan, DG
    Fleming, WH
    Geller, RB
    Heffner, LT
    Hillyer, CD
    Holden, J
    Holland, K
    Jones, W
    Mccollum, J
    Mogul, M
    Phillips, C
    Rodey, G
    Wingard, JR
    Winton, E
    Yeager, AM
    Devine, S
    CANCER RESEARCH THERAPY & CONTROL, 1998, 5 (04): : 221 - 228
  • [7] Membranous Nephropathy Associated with Donor Lymphocyte Infusion following Allogeneic Bone Marrow Transplantation
    Yasuhiko Miyazaki
    Yasukiyo Mori
    Noriko Kishimoto
    Noriaki Matsumoto
    Katsuhiro Zen
    Ryuichi Amakawa
    Yuji Kishimoto
    Shirou Fukuhara
    International Journal of Hematology, 2003, 78 : 262 - 265
  • [8] Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation
    Miyazaki, Y
    Mori, Y
    Kishimoto, N
    Matsumoto, N
    Zen, K
    Amakawa, R
    Kishimoto, Y
    Fukuhara, S
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (03) : 262 - 265
  • [9] Donor lymphocyte infusion for treatment of hematological leukemia relapse in children after allogeneic bone marrow transplantation.
    Pieczonka, A
    Wachowiak, J
    Boruczkowski, D
    Leda, M
    Jólkowska, J
    Ladoñ, D
    Witt, M
    BONE MARROW TRANSPLANTATION, 2002, 30 : S63 - S63
  • [10] PROSPECTIVE MULTICENTER TRIAL OF DONOR BUFFY COAT INFUSION FOR RELAPSED HEMATOLOGIC MALIGNANCY POST-ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
    COLLINS, R
    WOLFF, S
    LIST, A
    CHRISTIANSEN, N
    PINEIRO, L
    GREER, J
    GOODMAN, S
    DALTON, W
    GONZALEZ, G
    HERZIG, G
    PHILLIPS, G
    FAY, J
    BLOOD, 1994, 84 (10) : A333 - A333